Baillie Gifford - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$495,068,448
-12.9%
18,241,284
-1.4%
0.45%
-6.4%
Q2 2023$568,708,076
-16.6%
18,500,588
-2.2%
0.48%
-21.5%
Q1 2023$681,642,562
+0.8%
18,918,750
+10.5%
0.62%
-12.8%
Q4 2022$676,554,025
-5.8%
17,119,282
-4.2%
0.70%
-4.7%
Q3 2022$717,943,000
-5.1%
17,868,175
-0.7%
0.74%
-4.6%
Q2 2022$756,506,000
+1622.9%
17,994,918
+1496.7%
0.78%
+2403.2%
Q1 2022$43,909,0001,127,0310.03%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders